August 2014

TapImmune, Inc. Announces $2 Million Registered Direct OfferingStockhouseTapImmune, Inc. (the “Company”), (OTCQB:TPIV), today announced that it has entered into a definitive agreement with an institutional investor for a registered direct placement of $2,000,000 of common stock at a price of $1.06 per share. In addition … and more …read more

TapImmune, Inc. Announces $2 Million Registered Direct OfferingWall Street JournalIn addition, the Company will issue to the investor warrants to purchase up to 1,886,793 shares of common stock. The warrants have an exercise price of $1.17 per share and are exercisable for five years following issuance. The offering is expected to … and more …read

Centrue Financial Corporation Announces Agreement for Proposed $75.0 …CNNMoney… Company’s Series C Preferred Stock, cancellation and settlement of warrants to purchase the Company’s common stock held by the United States Department of Treasury, repayment or other settlement of the Company’s existing subordinated debt facility, … …read more

Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of …MarketWatchThe warrant transactions could have a dilutive effect to the extent that the market price per share of Aegerion’s common stock exceeds the applicable strike price of the warrants on any expiration date of the warrants. In addition, if the initial … …read more

Aegerion Pharmaceuticals, Inc. Announces Intention to Offer $250 Million of …MarketWatchThe warrant transactions could have a dilutive effect to the extent that the market price per share of Aegerion’s common stock exceeds the applicable strike price of the warrants on any expiration date of the warrants. In addition, if the initial … and more …read